Skip to main content
See every side of every news story
Published loading...Updated

Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks

WHO said 20,000 doses will go to a Phase 3 trial and 50,000 to health workers as Congo battles a fast-spreading outbreak.

  • On Thursday, the World Health Organization and partners announced that Congo will receive 70,000 doses of the Ervebo vaccine, a critical step to contain the fastest-spreading Ebola outbreak in history.
  • Driven by the rare Bundibugyo virus, the outbreak has resulted in 2,476 deaths among 5,208 confirmed cases, with the case fatality rate averaging 47.5% and reaching up to 70% in North Kivu province.
  • The allocation includes 20,000 doses for a Phase 3 clinical trial to understand the vaccine's impact on Bundibugyo, with 50,000 doses reserved for frontline workers; early laboratory data suggest it might provide some protection.
  • WHO Director-General Tedros Adhanom Ghebreyesus called the approval an "important example of global solidarity in action," while the International Coordinating Group will release doses immediately upon Congo's request.
  • Experts note the virus is spreading three times faster than the 2014–2016 West Africa outbreak, which caused more than 11,000 deaths, and likely began spreading from the mining town of Mongbwalu as early as February.
Insights by Ground AI

74 Articles

El DiarioEl Diario
+2 Reposted by 2 other sources
Center

The Democratic Republic of the Congo will receive 70 thousand doses of the Ervebo vaccine, which has been effective in previous Ebola outbreaks, reported today the World Health Organization (WHO) and its partners, announcing a step considered a great boost to efforts to contain what the authorities have described as the fastest Ebola outbreak in history. The Ervebo vaccine is authorized for use against the Ebola virus, one of the viruses that ca…

Far Left

“It is not known whether Ervebo can be protective against the Bundibugyo virus in humans,” said WHO, emphasizing the importance of clinical trials to provide new evidence.

·Caracas, Venezuela (Bolivarian Republic of)
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 36% of the sources are Center
36% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Winnipeg Free Press broke the news in Winnipeg, Canada on Thursday, August 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal